Alerts
Other content recommended for you
- Disease modifying therapies for relapsing multiple sclerosis
- Association of British Neurologists: revised (2015) guidelines for prescribing disease-modifying treatments in multiple sclerosis
- Drug treatment of multiple sclerosis
- UK multiple sclerosis risk-sharing scheme: a new natural history dataset and an improved Markov model
- Disease-modifying therapies for multiple sclerosis
- ▼Natalizumab for multiple sclerosis?
- Diagnosis and disease modifying treatments in multiple sclerosis
- Multiple sclerosis
- Problems with UK government's risk sharing scheme for assessing drugs for multiple sclerosis
- ▼Teriflunomide for multiple sclerosis